2nd Neuroimmunology Drug Discovery Summit, digital event - 5-7th August 2020

Transpharmation will be attending this virtual event. Neuroinflammation has become an important area for us as pharma and biotech companies increasingly see neuroimmunology and neuroinflammation as a target for the development of novel treatments for neurodegenerative diseases. Our recent work on the development of in vivo and in vitro models of LPS-induced neuroinflammation using multiplexed cytokine and chemokine analysis as an end point, offers a high-throughput and translational way of evaluating novel therapeutics.

2nd Neuroimmunology Drug Discovery Summit, digital event - 5-7th August 2020